-
#Precigen Completes Series Of Transactions To Solidify#Healthcare Focus$PGEN https://www.1stoncology.com/blog/precigen-completes-series-of-transactions-to-solidify-healthcare-focus1234553806 … -
Today is
#WorldCancerDay
. Join #Precigen as we strive to find new therapies for difficult-to-treat cancers. Together, we can advance medicine with precision in the pursuit of new treatment options.#IAmAndIWill
pic.twitter.com/21ysx9xgkg -
Congratulations to the
#Precigen team and our new shareholders for the start of a new chapter. We look forward to continuing to live by our brand promise to advance medicine with precision.$PGEN@nasdaq#Maryland#GeneTherapy#CellTherapy#Immunotherapy https://bit.ly/391JDLi pic.twitter.com/VhepwI0wLm
-
Welcome
#Precigen investors to http://investors.precigen.com . This new site provides the latest updates on$PGEN and our progress as we advance medicine with precision.#Maryland#biopharma@nasdaq#GeneTherapy#CellTherapy#Immunotherapy https://bit.ly/391JDLi pic.twitter.com/DqHN6ibWyS
-
Thank you
@MDTechCouncil for hosting the Annual Annapolis Day & Leadership Dinner.#Precigen enjoyed speaking with General Assembly Members about delivering innovative solutions to pressing healthcare challenges.#Biotechnology#CellTherapy#GeneTherapy#Maryland#MDGA20https://twitter.com/MDTechCouncil/status/1222518549622771713 …
-
Triple-Gene to highlight its investigational
#genetherapy in Phase 1 for treatment of#heartfailure at#BiotechShowcase TODAY January 15th at 11:30am PT in Franciscan B at the Hilton San Francisco Union Square$XON#Precigen#cardiovasculardisease#JPMHC20#JPM2020#JPMorgan2020pic.twitter.com/QkvSDJXSYy
-
At
#JPMHC20? Listen to Dr. Helen Sabzevari, President & CEO of@Precigen, at 5pm PT in California West present on#Precigen progress and 2020 look ahead OR watch live webcast here: http://ow.ly/2ndc50xVC11$XON#JPM2020#JPMorgan2020#GeneTherapy#CellTherapy#Immunotherapypic.twitter.com/7R0AOpVECr
-
#Precigen receives first regulatory designation for PRGN-3006 UltraCAR-T#OrphanDrugDesignation#immunotherapy#biotech https://prn.to/2ZThUcc pic.twitter.com/4TuSU92eD3
-
#Intrexon appoints Helen Sabzevari, PhD, as new President and CEO and will change name to#Precigen to reflect healthcare focus. Join us at#JPM2020 on January 14 at 5pm PT to hear Helen's vision for the new Precigen#Maryland#Biotech https://prn.to/35hOHsG pic.twitter.com/AFQCEvpSxr
-
Team
#Precigen celebrates the holidays in our#Germantown#Maryland offices!#HappyHolidays from our family to yourspic.twitter.com/MViHcqqXGM
-
UltraCAR T cells for the treatment of AML and MDS
#Precigen https://twitter.com/Precigen/status/1197011154490421248 …
-
#Precigen will host a conference call to provide business and pipeline updates on November 12, 2019 at 11:00 AM ET. Register to participate https://bit.ly/32kWdBL$XON#immunotherapy#genetherapy#celltherapy#Marylandpic.twitter.com/kWSVHPUD8a
-
@MDBiz Secretary@KellyMSchulz tours#Precigen’s gene therapy manufacturing facility with President Dr. Helen Sabzevari and Precigen team members Rutul Shah and Bryan Butman#Maryland#PrecisionMedicine#GeneTherapy#ImmunoOncology$XONpic.twitter.com/Qx6zKcm59G
-
Thank you
@HBAnet for an engaging panel discussion on personalized medicine and gene therapy hosted at#Precigen’s headquarters in#Germantown#Maryland.#PrecisionMedicine#GeneTherapy#WomeninBiopic.twitter.com/ygMiOPV1f3
-
Breaking News: Intrexon Reports Second Quarter and First Half 2019 Financial Results: https://bit.ly/2YTf1Kv
#Precigen#MethaneBioconversionPlatform#Oxitec#ActoBioTherapeutics#Triple-Gene#Cannabinoid#Non-BrowningLettuce#ExemplarGenetics -
#Intrexon's Subsidiary#Precigen to Present at the JMP Securities#LifeSciencesConference$XON http://www.1stoncology.com/blog/intrexon-s-subsidiary-precigen-to-present-at-the-jmp-securities-life-sciences-conference1234537068 … -
-
-
Looking ahead in 2019:
#Precigen to rapidly advance#clinical and#preclinical programs.#Investor Day Webcast now available on demand: https://bit.ly/2QvmQ0z .#JPM19#BioTechShowcase#Oncology#Cancer#InfectiousDisease#AutoimmuneDisorders$XONpic.twitter.com/r5YXadKWuV
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.